BAYER AG
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A
- First Posted Date
- 2020-09-25
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 45
- Registration Number
- NCT04565236
- Locations
- 🇨🇳
Shijiazhuang General Hospital, Shijiazhuang, Hebei, China
🇨🇳NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School, Nanjing, Jiangsu, China
🇨🇳1st Affiliated hospital of Soochow University, Suzhou, Jiangsu, China
Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough
- Conditions
- Interventions
- First Posted Date
- 2020-09-24
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 310
- Registration Number
- NCT04562155
- Locations
- 🇧🇪
VZW Emmaus, Mechelen, Belgium
🇭🇺Da Vinci Maganklinika, Pecs, Hungary
🇭🇺Farmakontroll Bt., Szazhalombatta, Hungary
Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease
- Conditions
- Interventions
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2022-08-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 7
- Registration Number
- NCT04552262
- Locations
- 🇩🇰
Steno Diabetes Center Copenhagen, Herlev, Denmark
Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)
- First Posted Date
- 2020-09-11
- Last Posted Date
- 2022-12-22
- Lead Sponsor
- Bayer
- Target Recruit Count
- 99
- Registration Number
- NCT04545580
- Locations
- 🇦🇹
Medizinische Universität Graz, Graz, Steiermark, Austria
🇵🇹Centro Hospitalar Universitario do Porto, Porto, Portugal
🇦🇺Emeritus Research, Camberwell, Victoria, Australia
Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug
- Conditions
- Interventions
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2023-07-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 307
- Registration Number
- NCT04534114
- Locations
- 🇨🇦
Unity Health Toronto: St. Michael's Hospital, Toronto, Ontario, Canada
🇺🇸Desert Cities Dialysis-Amethyst & Desert Cities Dialysis, Victorville, California, United States
🇺🇸Fresenius Kidney Care Clovis, Clovis, California, United States
Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.
- Conditions
- Interventions
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2020-11-12
- Lead Sponsor
- Bayer
- Target Recruit Count
- 50
- Registration Number
- NCT04534465
- Locations
- 🇺🇸
Merck Consumer Center, Memphis, Tennessee, United States
Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 855
- Registration Number
- NCT04534491
- Locations
- 🇺🇸
Stevenson Family Pharmacy, Saint Joseph, Missouri, United States
Study to Find Out Whether Participants With a History of Stuffy Nose Due to Allergic Reactions in the Nose Would Intend to Buy Drug Phenylephrine Hydrochloride Extended Release Tablets After Receiving it Once in This Study
- Conditions
- Interventions
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2020-09-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 347
- Registration Number
- NCT04534452
- Locations
- 🇺🇸
Allergy & Asthma Specialists, PC, Blue Bell, Pennsylvania, United States
Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy Participants
- Conditions
- Interventions
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 137
- Registration Number
- NCT04532164
Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)
- Conditions
- Interventions
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 32
- Registration Number
- NCT04531813